You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Hepatocellular

Showing 26 - 50 of 9,618
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Taoyuan City, Taiwan
    Chang Gung Memorial Hospital at Linkou
Nov 17, 2023

Paraneoplastic Syndrome in Hepatocellular Carcinoma Patients

Recruiting
  • Hepatocellular Carcinoma Patients
  • Triphasic C.T abdomen and pelvis
  • Sohag, Egypt
    Sohag University hospitals
Apr 26, 2023

Hepatocellular Carcinoma Trial in Shanghai (BC3402 injection, Durvalumab injection)

Not yet recruiting
  • Hepatocellular Carcinoma
  • BC3402 injection
  • Durvalumab injection
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Oct 26, 2023

Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)

Not yet recruiting
  • Hepatocellular Carcinoma
  • TACE（transcatheter arterial chemoembolization）
  • +2 more
  • (no location specified)
Jun 5, 2023

Adebrelimab, Hepatocellular Carcinoma, Transformation Trial in Xiamen (TACE with adebrelimab and bevacizumab)

Not yet recruiting
  • Adebrelimab
  • +4 more
  • TACE with adebrelimab and bevacizumab
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Jul 25, 2023

Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guangzhou (bTAE-HAIC, Lenvatinib, Sintilimab)

Not yet recruiting
  • Liver Diseases
  • +4 more
  • bTAE-HAIC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 30, 2023

Key Genes in Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Carcinoma
  • None of intervention
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023

Magnetic Resonance Imaging, Hepatocellular Carcinoma, Screening Trial in Lausanne (MRI)

Recruiting
  • Magnetic Resonance Imaging
  • +3 more
  • MRI
  • Lausanne, Vaud, Switzerland
    Lausanne University Hospital
Apr 12, 2023

Advanced Hepatocellular Carcinoma Trial (SZ003 CAR-NK)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • SZ003 CAR-NK
  • (no location specified)
Apr 25, 2023

Hepatocellular Carcinoma Trial in Shanghai (Cadonilimab+TACE)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Jun 21, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 15, 2023

Resectable Hepatocellular Carcinoma Trial (Tislelizumab, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • (no location specified)
Mar 29, 2023

Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Anlotinib and TQB2450
  • Shanghai, Shanghai, China
    Zhongshan hospital
Sep 4, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (adebrelimab, camrelizumab plus apatinib)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • adebrelimab, camrelizumab plus apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Jun 21, 2023

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Hepatitis B Virus Reactivation:Cautionary Event After Liver

Completed
  • Liver Transplant; Complications
  • Diagnosis of postoperative recurrence of liver cancer
  • (no location specified)
Oct 27, 2023

Liver Cirrhosis, Hepatocellular Carcinoma Trial (Elecsys® GAAD)

Not yet recruiting
  • Liver Cirrhosis
  • Hepatocellular Carcinoma
  • Elecsys® GAAD
  • (no location specified)
Aug 4, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib, sintilimab plus SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023

Hepatocellular Carcinoma Trial in Hangzhou (PVE+cTACE+Camrelizumab+Apatinib, cTACE+Atirizumab+Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • PVE+cTACE+Camrelizumab+Apatinib
  • cTACE+Atirizumab+Bevacizumab
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023

Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)

Not yet recruiting
  • Stage IIIA Hepatocellular Carcinoma
  • Radiotherapy combined with TKI and Anti-PD-1 Antibody
  • (no location specified)
Sep 24, 2023

Hepatocellular Carcinoma Trial (Irinotecan, Sonidegib, Sorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Dec 20, 2022

Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

Recruiting
  • Liver Carcinoma
  • Hepatic Cell Carcinoma
  • CAR-GPC3 T cells
  • Wuhan, Hubei, China
    Tao Zhang
Nov 20, 2023

Hepatocellular Carcinoma Trial in Seoul (AtezoBev with combined radiotherapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AtezoBev with combined radiotherapy
  • Seoul, Korea, Republic of
    Severance hospital
Jun 9, 2023

Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • camrelizumab for Injection
  • (no location specified)
Nov 13, 2023